AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 251 filers reported holding AVANOS MED INC in Q3 2023. The put-call ratio across all filers is 1.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $922 | -34.4% | 45,600 | -17.1% | 0.01% | -33.3% |
| Q2 2023 | $1,406 | -0.3% | 55,000 | +16.0% | 0.01% | -10.0% |
| Q1 2023 | $1,410 | -99.6% | 47,400 | +251.7% | 0.01% | +233.3% |
| Q2 2022 | $368,000 | -31.5% | 13,476 | -16.0% | 0.00% | 0.0% |
| Q1 2022 | $537,000 | -35.1% | 16,044 | -33.2% | 0.00% | -25.0% |
| Q4 2021 | $828,000 | +10.5% | 24,007 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $749,000 | +1191.4% | 24,007 | +1418.5% | 0.00% | – |
| Q2 2021 | $58,000 | -15.9% | 1,581 | 0.0% | 0.00% | – |
| Q1 2021 | $69,000 | -5.5% | 1,581 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $73,000 | +37.7% | 1,581 | 0.0% | 0.00% | – |
| Q3 2020 | $53,000 | +15.2% | 1,581 | 0.0% | 0.00% | – |
| Q2 2020 | $46,000 | +7.0% | 1,581 | 0.0% | 0.00% | – |
| Q1 2020 | $43,000 | -18.9% | 1,581 | 0.0% | 0.00% | – |
| Q4 2019 | $53,000 | -10.2% | 1,581 | 0.0% | 0.00% | – |
| Q3 2019 | $59,000 | -14.5% | 1,581 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $69,000 | – | 1,581 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,482,743 | $113,908,000 | 6.40% |
| RGM Capital, LLC | 1,984,455 | $91,047,000 | 3.97% |
| Cove Street Capital, LLC | 204,438 | $9,380,000 | 1.66% |
| Millrace Asset Group, Inc. | 41,200 | $1,890,000 | 1.32% |
| Phocas Financial Corp. | 142,037 | $6,516,000 | 1.00% |
| Champlain Investment Partners, LLC | 3,470,935 | $159,246,000 | 0.91% |
| HEARTLAND ADVISORS INC | 231,533 | $10,623,000 | 0.76% |
| CONFLUENCE INVESTMENT MANAGEMENT LLC | 481,042 | $22,070,000 | 0.33% |
| Wakefield Asset Management LLLP | 14,653 | $672,000 | 0.28% |
| S.A. Mason LLC | 6,527 | $299,000 | 0.25% |